Lavipharm S.A Capital Reinvestment Ratio
Lavipharm S.A capital reinvestment ratio. Lavipharm S.A (LAVI) has a Capital Reinvestment Ratio of 33.32x as of December 2022, meaning it reinvests 33% of its operating cash flow (€527.00K) in capital expenditures (€17.56 Million). Check LAVI cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Lavipharm S.A (2014–2024)
Capital reinvestment ratio of Lavipharm S.A from 2014 to 2024. This chart tracks Lavipharm S.A's Capital Reinvestment Ratio across 11 annual periods. Also explore LAVI shareholders equity momentum to track the company's year-over-year net asset growth rate.
Lavipharm S.A Capital Reinvestment Ratio by Year (2014–2024)
Lavipharm S.A capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see how efficiently does Lavipharm S.A generate cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.08x | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €284.00K | €4.05 Million | ▲ +34.0% |
| 2022 | 10.64x | €3.35 Million | €35.62 Million | ▲ +2020.0% |
| 2021 | 0.50x | €3.82 Million | €1.92 Million | ▼ -3.1% |
| 2020 | 0.52x | €2.85 Million | €1.48 Million | ▼ -38.0% |
| 2019 | 0.84x | €2.89 Million | €2.42 Million | ▲ +14.7% |
| 2018 | 0.73x | €1.42 Million | €1.03 Million | ▲ +215.0% |
| 2017 | 0.23x | €1.51 Million | €350.00K | ▲ +44.4% |
| 2016 | 0.16x | €606.00K | €97.00K | ▲ +300.9% |
| 2015 | 0.04x | €576.00K | €23.00K | ▼ -92.1% |
| 2014 | 0.51x | €2.38 Million | €1.20 Million | — |